Search Results - "Amrutkar, Manoj"
-
1
Pancreatic Cancer Chemoresistance to Gemcitabine
Published in Cancers (16-11-2017)“…Pancreatic ductal adenocarcinoma (PDAC), commonly referred to as pancreatic cancer, ranks among the leading causes of cancer-related deaths in the Western…”
Get full text
Journal Article -
2
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
Published in BMC cancer (17-06-2019)“…Gemcitabine remains a cornerstone in chemotherapy of pancreatic ductal adenocarcinoma (PDAC) despite suboptimal clinical effects that are partly due to the…”
Get full text
Journal Article -
3
Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice
Published in International journal of molecular sciences (01-02-2024)“…Metabolic dysfunction-associated steatotic liver disease (MASLD) and its advanced subtype, metabolic dysfunction-associated steatohepatitis (MASH), have…”
Get full text
Journal Article -
4
Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells
Published in Cancer cell international (17-11-2023)“…Abstract Background Despite therapeutic advances, the prognosis of pancreatic ductal adenocarcinoma (PDAC) remains extremely poor. Metabolic reprogramming is…”
Get full text
Journal Article -
5
Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma
Published in Molecular oncology (01-01-2023)“…The modest clinical benefits of neoadjuvant chemotherapy (NAT) in pancreatic ductal adenocarcinoma (PDAC) are associated with a lack of robust data on…”
Get full text
Journal Article -
6
STK25 is a critical determinant in nonalcoholic steatohepatitis
Published in The FASEB journal (01-10-2016)“…ABSTRACT Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and 10–20% of patients with NAFLD progress to nonalcoholic…”
Get full text
Journal Article -
7
Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model
Published in Diabetes (New York, N.Y.) (01-08-2015)“…Understanding the molecular networks controlling ectopic lipid deposition, glucose tolerance, and insulin sensitivity is essential to identifying new…”
Get full text
Journal Article -
8
Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis
Published in Cancer cell international (19-01-2023)“…Profound resistance to chemotherapy remains a major challenge in achieving better clinical outcomes for patients with pancreatic ductal adenocarcinoma (PDAC)…”
Get full text
Journal Article -
9
Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells
Published in Cells (Basel, Switzerland) (01-01-2019)“…Activated pancreatic stellate cells (PSCs) play a central role in the tumor stroma of pancreatic ductal adenocarcinoma (PDAC). Given the limited availability…”
Get full text
Journal Article -
10
Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor
Published in Cells (Basel, Switzerland) (16-01-2020)“…Pancreatic ductal adenocarcinoma (PDAC) is characterized by an extremely poor prognosis, and its treatment remains a challenge. As the existing in vitro…”
Get full text
Journal Article -
11
Mo1138 COMPARATIVE PROTEOMICS REVEALS TRANSLATIONAL POTENTIAL OF TARGETS FOR PANCREATIC DUCTAL ADENOCARCINOMA
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2023)Get full text
Journal Article -
12
Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer
Published in Cancers (03-02-2021)“…Pancreatic ductal adenocarcinoma (PDAC), also known as pancreatic cancer (PC), is characterized by an overall poor prognosis and a five-year survival that is…”
Get full text
Journal Article -
13
Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes
Published in Molecular and cellular endocrinology (15-08-2013)“…•Activation of AMPK represses IL-6-induced inflammation in liver and HepG2 cells.•AMPK inhibits IL-6 signalling by repressing phosphorylation of JAK1, SHP2 and…”
Get full text
Journal Article -
14
Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH
Published in The FASEB journal (01-04-2015)“…Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease, and 10% to 20% of NAFLD patients progress to nonalcoholic steatohepatitis…”
Get full text
Journal Article -
15
Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems
Published in Seminars in cancer biology (01-11-2024)“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor prognosis and rising global deaths. Late diagnosis, due to absent early symptoms and…”
Get full text
Journal Article -
16
Silencing of STE20‐type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet‐induced nonalcoholic fatty liver disease
Published in The FASEB journal (01-05-2021)“…Nonalcoholic fatty liver disease (NAFLD) is emerging as a leading cause of chronic liver disease worldwide. Despite intensive nonclinical and clinical research…”
Get full text
Journal Article -
17
Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer
Published in Molecular oncology (15-11-2024)“…Neoadjuvant chemotherapy (NAT) is increasingly used for the treatment of non‐metastatic pancreatic ductal adenocarcinoma (PDAC) and is established as a…”
Get full text
Journal Article -
18
Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans
Published in The FASEB journal (01-09-2019)“…ABSTRACTEctopic lipid storage in the liver is considered the main risk factor for nonalcoholic steatohepatitis (NASH). Understanding the molecular networks…”
Get full text
Journal Article -
19
Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans
Published in Diabetologia (01-02-2016)“…Aims/hypothesis Type 2 diabetes is closely associated with pathological lipid accumulation in the liver, which is suggested to actively contribute to the…”
Get full text
Journal Article -
20
Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle
Published in Diabetologia (01-03-2017)“…Aims/hypothesis Understanding the molecular networks controlling ectopic lipid deposition and insulin responsiveness in skeletal muscle is essential for…”
Get full text
Journal Article